← Leaderboards
David Charles Irwin
University Of Colorado Denver
$10,493,842
Attributed
$17,908,594
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,908,594 · 9
By mechanism
R01$12,409,625 · 5
P01$5,498,969 · 4
Top collaborators
- Paul Werner Buehler16 shared
- Andre Francis Palmer12 shared
- Pedro Cabrales8 shared
- Angelo D'Alessandro4 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Kurt R Stenmark$22,132,904
- Paul Werner Buehler$4,588,385
- Karen A Fagan$2,747,862
- Clifford R Greyson$1,366,434
- Andre Francis Palmer$9,637,181
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungHypoxiaTissuesRattusAnimal ModelHemoglobinPulmonary HypertensionHemodynamicsMediatingAnimalsCardiac OutputCellsHemolysisOrganMethodologyPlasmaIn VivoIn VitroSeveritiesVascular RemodelingBlood VesselsChronicCathetersHeart Function
Grant awards (35)
The paradoxical response to iron in pulmonary hypertension of sickle cell disease$666,831
R01 · FY2025 · HL · contact PI
Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis$631,536
R01 · FY2025 · HL
Aerosolized therapy for hemoglobin toxicity in the treatment of hemolytic diseases$623,543
R01 · FY2025 · HL · contact PI
The paradoxical response to iron in pulmonary hypertension of sickle cell disease$657,115
R01 · FY2024 · HL · contact PI
Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis$629,898
R01 · FY2024 · HL
Bioengineering a Dual Function Protein Construct to Detoxify Heme and Hemoglobin$625,741
R01 · FY2024 · HL
Aerosolized therapy for hemoglobin toxicity in the treatment of hemolytic diseases$611,072
R01 · FY2024 · HL · contact PI
Animal Core$603,172
P01 · FY2024 · HL · contact PI
The paradoxical response to iron in pulmonary hypertension of sickle cell disease$674,111
R01 · FY2023 · HL · contact PI
Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis$653,723
R01 · FY2023 · HL
Bioengineering a Dual Function Protein Construct to Detoxify Heme and Hemoglobin$646,411
R01 · FY2023 · HL
Aerosolized therapy for hemoglobin toxicity in the treatment of hemolytic diseases$623,543
R01 · FY2023 · HL · contact PI
Animal Core$615,481
P01 · FY2023 · HL · contact PI
The paradoxical response to iron in pulmonary hypertension of sickle cell disease$711,122
R01 · FY2022 · HL · contact PI
Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis$701,968
R01 · FY2022 · HL
Bioengineering a Dual Function Protein Construct to Detoxify Heme and Hemoglobin$656,753
R01 · FY2022 · HL
Aerosolized therapy for hemoglobin toxicity in the treatment of hemolytic diseases$648,518
R01 · FY2022 · HL · contact PI
Animal Core$615,481
P01 · FY2022 · HL · contact PI
Bioengineering a Dual Function Protein Construct to Detoxify Heme and Hemoglobin$703,990
R01 · FY2021 · HL
Animal Core$615,481
P01 · FY2021 · HL · contact PI
Animal Core$398,710
P01 · FY2020 · HL · contact PI
The contribution of free hemoglobin in the progression of pulmonary remodeling$388,750
R01 · FY2019 · HL · contact PI
The contribution of free hemoglobin in the progression of pulmonary remodeling$388,750
R01 · FY2018 · HL · contact PI
Animal Core D$306,522
P01 · FY2018 · HL · contact PI
The contribution of free hemoglobin in the progression of pulmonary remodeling$388,750
R01 · FY2017 · HL · contact PI
Animal Core D$306,522
P01 · FY2017 · HL · contact PI
The contribution of free hemoglobin in the progression of pulmonary remodeling$388,750
R01 · FY2016 · HL · contact PI
Animal Core D$306,522
P01 · FY2016 · HL · contact PI
The contribution of free hemoglobin in the progression of pulmonary remodeling$388,750
R01 · FY2015 · HL · contact PI
Animal Core D$306,522
P01 · FY2015 · HL · contact PI
Animal Core$271,498
P01 · FY2013 · HL · contact PI
Animal Core$313,370
P01 · FY2012 · HL · contact PI
Animal Core$283,883
P01 · FY2011 · HL · contact PI
Animal Core$277,450
P01 · FY2010 · HL · contact PI
Animal Core$278,355
P01 · FY2009 · HL · contact PI